Categories of hypertension in the elderly and their 1-year evolution. The Three-City Study

Journal of Hypertension

Volumn 31, Issue 4, 2013, Pages 680-689

  Cacciolati, Cécilia ^a,e   Hanon, Olivier ^c,d   Dufouil, Carole ^a,e   Alpérovitch, Annick ^a,b   Tzourio, Christophe ^a,e  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d Paris Descartes University   (France)

^e UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

cohort study; elderly; masked hypertension; prognosis; white coat hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ELDERLY CARE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

EID: 84875228294     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32835ee0ca     Document Type: Article

References (31)

1. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008; 26:1505-1526.
2. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, et al. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the international database on ambulatory blood pressure monitoring in relation to cardiovascular outcomes population. Hypertension 2012; 59:564-571.
3. Verdecchia P, Reboldi GP, Angeli F, Schillaci G, Schwartz JE, Pickering TG, et al. Short- and long-term incidence of stroke in white-coat hypertension. Hypertension 2005; 45:203-208.
4. Bobrie G, Clerson P, Menard J, Postel-Vinay N, Chatellier G, Plouin PF. Masked hypertension: a systematic review. J Hypertens 2008; 26:1715- 1725.
5. Verdecchia P, Angeli F, Gattobigio R, Borgioni C, Castellani C, Sardone M, Reboldi G. The clinical significance of white-coat and masked hypertension. Blood Press Monit 2007; 12:387-389.
6. Obara T, Ohkubo T, Imai Y. Long-term risk in subjects with white-coat hypertension. Hypertension 2009; 54:e133.
7. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, et al. Cardiovascular prognosis of 'masked hypertension' detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004; 291:1342-1349.
8. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988; 259:225-228.
9. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006; 47:846-853.
10. Pierdomenico SD, Cuccurullo F. Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 2010; 24:52-58.
11. Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007; 25:2193-2198.
12. Alperovitch A. Vascular factors and risk of dementia: design of the three-city study and baseline characteristics of the study population. Neuroepidemiology 2003; 22:316-325.
13. Cacciolati C, Hanon O, Alperovitch A, Dufouil C, Tzourio C. Masked hypertension in the elderly: cross-sectional analysis of a populationbased sample. Am J Hypertens 2011; 24:674-680.
14. Altunkan S, Iliman N, Altunkan E. Validation of the Omron M6 (HEM- 7001-E) upper arm blood pressure measuring device according to the International Protocol in elderly patients. Blood Press Monit 2008; 13:117-122.
15. Stergiou GS, Skeva II, Zourbaki AS, Mountokalakis TD. Self-monitoring of blood pressure at home: how many measurements are needed? J Hypertens 1998; 16:725-731.
16. Ragot S, Genes N, Vaur L, Herpin D. Comparison of three blood pressure measurement methods for the evaluation of two antihypertensive drugs: feasibility, agreement, and reproducibility of blood pressure response. Am J Hypertens 2000; 13:632-639.
17. Staessen JA, Thijs L, Ohkubo T, Kikuya M, Richart T, Boggia J, et al. Thirty years of research on diagnostic and therapeutic thresholds for the self-measured blood pressure at home. Blood Press Monit 2008; 13:352-365.
18. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al.ESH-ESC practice guidelines for the management of arterial hypertension: ESH-ESC task force on the management of arterial hypertension. J Hypertens 2007; 25:1751-1762.
19. Alperovitch A, Lacombe JM, Hanon O, Dartigues JF, Ritchie K, Ducimetiere P, Tzourio C. Relationship between blood pressure and outdoor temperature in a large sample of elderly individuals: the Three-City study. Arch Intern Med 2009; 169:75-80.
20. WHO Collaborating Centre for Drug Statistics Methodology, ATC classification index with DDDs, 2010. Oslo, Norway: WHO Collaborating Centre; 2009; http://www.whocc.no/filearchive/publications/ 2010guidelines.pdf.
21. Samieri C, Feart C, Proust-Lima C, Peuchant E, Tzourio C, Stapf C, et al. Olive oil consumption, plasma oleic acid, and stroke incidence: The Three-City Study. Neurology 2011; 77:418-425.
22. Dufouil C, Richard F, Fievet N, Dartigues JF, Ritchie K, Tzourio C, et al. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study. Neurology 2005; 64:1531-1538.
23. Breton G, Froissart M, Janus N, Launay-Vacher V, Berr C, Tzourio C, et al. Inappropriate drug use and mortality in community-dwelling elderly with impaired kidney function: the Three-City populationbased study. Nephrol Dial Transplant 2011; 26:2852-2859.
24. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
25. Vasan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in nonhypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001; 358:1682-1686.
26. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011; 30:377- 399.
27. van Buuren S, Boshuizen HC, Knook DL. Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999; 18:681-694.
28. Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Friz HP, et al. Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension 2009; 54:226-232.
29. Ugajin T, Hozawa A, Ohkubo T, Asayama K, Kikuya M, Obara T, et al. White-coat hypertension as a risk factor for the development of home hypertension: the Ohasama study. Arch Intern Med 2005; 165:1541- 1546.
30. Palatini P, Winnicki M, Santonastaso M, Mos L, Longo D, Zaetta V, et al. Prevalence and clinical significance of isolated ambulatory hypertension in young subjects screened for stage 1 hypertension. Hypertension 2004; 44:170-174.
31. Hansen TW, Kikuya M, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens 2007; 25:1554-1564.